Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Dynamiker Biotechnology (Tianjin) Co's quarterly market cap
increased
from Sep. 2025 (¥0.0 Mil) to Dec. 2025 (¥4,203.5 Mil) but then
declined
from Dec. 2025 (¥4,203.5 Mil) to Mar. 2026 (¥3,532.8 Mil).
Dynamiker Biotechnology (Tianjin) Co's annual market cap
stayed the same
from Dec. 2023 (¥0.0 Mil) to Dec. 2024 (¥0.0 Mil) but then
increased
from Dec. 2024 (¥0.0 Mil) to Dec. 2025 (¥4,203.5 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Dynamiker Biotechnology (Tianjin) Co's Enterprise Value for Today is ¥2,443.1 Mil.
Dynamiker Biotechnology (Tianjin) Co (BJSE:920009) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Dynamiker Biotechnology (Tianjin) Co Market Cap Related Terms
Dynamiker Biotechnology (Tianjin) Co Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dynamiker Biotechnology (Tianjin) Co Market Cap Chart
BJSE:920009 vs LLY, JNJ, ABBV: Market Cap Comparison
For the Drug Manufacturers - General subindustry, Dynamiker Biotechnology (Tianjin) Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dynamiker Biotechnology (Tianjin) Co Market Cap vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Dynamiker Biotechnology (Tianjin) Co's Market Cap distribution charts can be found below:
* The bar in red indicates where Dynamiker Biotechnology (Tianjin) Co's Market Cap falls into.
Dynamiker Biotechnology (Tianjin) Co Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dynamiker Biotechnology (Tianjin) Co (BJSE:920009) has a Market Cap of ¥2,846.7 Mil as of Aug. 19, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Dynamiker Biotechnology (Tianjin) Co and its competitors. According to the industry distribution chart, Dynamiker Biotechnology (Tianjin) Co ranks #431 out of 1021 companies in the Drug Manufacturers industry, placing it in the top 42.2%.
Is Dynamiker Biotechnology (Tianjin) Co's Market Cap too high?
Dynamiker Biotechnology (Tianjin) Co's current Market Cap is ¥2,846.7 Mil. Based on the distribution chart, Dynamiker Biotechnology (Tianjin) Co ranks #431 out of 1021 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Dynamiker Biotechnology (Tianjin) Co has a GF Score™ of 46/100, reflecting its overall financial health beyond just this single metric.
How does Dynamiker Biotechnology (Tianjin) Co's Market Cap compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Dynamiker Biotechnology (Tianjin) Co ranks #431 out of 1021 companies for Market Cap. This puts Dynamiker Biotechnology (Tianjin) Co in the upper half of its industry. The industry median Market Cap is 229.68. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 229.68, based on 1,021 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Dynamiker Biotechnology (Tianjin) Co and its competitors. For the Drug Manufacturers industry, the median Market Cap is 229.68 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dynamiker Biotechnology (Tianjin) Co's current Market Cap is ¥2,846.7 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dynamiker Biotechnology (Tianjin) Co stock overvalued right now?
Dynamiker Biotechnology (Tianjin) Co (BJSE:920009) has a current Market Cap of ¥2,846.7 Mil. The current Market Cap is ¥2,846.7 Mil. Dynamiker Biotechnology (Tianjin) Co's overall GF Score™ is 46/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Dynamiker Biotechnology (Tianjin) Co (BJSE:920009), the current Market Cap is ¥2,846.7 Mil as of Aug. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Dynamiker Biotechnology (Tianjin) Co Ltd specializes in R&D, production, and sales of early serological diagnosis of invasive mycosis and in vitro diagnostic products for other pathogenic microorganisms.
46GF Score
Get the complete analysis for BJSE:920009
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BJSE:920009 has been successfully added to your 
